Log in or Sign up for Free to view tailored content for your specialty!
CHD/Prevention News
GLP-1, SGLT2 prescriptions for type 1 diabetes rising despite no regulatory approval
Prescriptions for GLP-1 receptor agonists and SGLT2 inhibitors for patients with type 1 diabetes rose between 2010 and 2023 despite not being approved for that population, according to a research letter published in JAMA.
VIDEO: Martha Gulati, MD, on practical solutions to improve CV outcomes in women
BOSTON — In this Healio video exclusive, Martha Gulati, MD, MS, FACC, FAHA, FASPC, discusses her presentation at the Cardiometabolic Health Congress, “How to Improve Cardiovascular Outcomes in Women.”
Log in or Sign up for Free to view tailored content for your specialty!
Recurrent pregnancy loss may raise risk for hypertensive disorders among Black women
DENVER — Black women with a history of recurrent pregnancy loss had a higher likelihood of developing hypertensive disorders of pregnancy, delivering offspring earlier and delivering offspring with lower birth weights, researchers reported.
Common PCOS treatments do not increase, decrease metabolic syndrome risk
DENVER — For women with polycystic ovary syndrome and overweight or obesity, neither oral contraceptive pills nor metformin altered the characteristic markers of metabolic syndrome, either alone or in combination, researchers reported.
VIDEO: Pay attention to CV risk in young adults, measure Lp(a)
BOSTON — In this Healio video exclusive, Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, discusses her presentation at the Cardiometabolic Health Congress, “Primary Prevention of CVD: The Sooner the Better?”
Oral semaglutide prevents CV events in people with diabetes and heart disease, CKD
Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.
New stroke primary prevention guideline calls for more screening of risk factors
The new guideline on primary prevention of stroke from the American Heart Association and American Stroke Association calls for more screening of risk factors such as high BP, high cholesterol and high blood glucose.
Bariatric surgery more cost-effective than GLP-1s in long term
At current prices, bariatric surgery was more cost-effective than GLP-1 receptor agonists for treatment of obesity, researchers reported at the American College of Surgeons Clinical Congress.
Medication hesitancy when addressing patients’ obesity-related atherosclerotic risk
BOSTON — In a survey, cardiology physicians expressed hesitancy to prescribe currently available obesity medications, preferring exercise and dietary interventions, but with little personalized tailoring for patients, researchers reported.
Speakers highlight 2024 regulatory moves in hypertension, lipid, diabetes therapies
There have been many recent regulatory updates in the areas of blood pressure management, dyslipidemia and diabetes management, speakers reported.
-
Headline News
Fauci: HIV, COVID-19 pandemics taught us to ‘expect the unexpected’
December 10, 20244 min read -
Headline News
‘Dealing with a time bomb’: Persistent tobacco smoking tied to cardiac injury at young age
December 11, 20243 min read -
Headline News
Women less likely to use promotional language in research grant applications vs. men
December 11, 20243 min read
-
Headline News
Fauci: HIV, COVID-19 pandemics taught us to ‘expect the unexpected’
December 10, 20244 min read -
Headline News
‘Dealing with a time bomb’: Persistent tobacco smoking tied to cardiac injury at young age
December 11, 20243 min read -
Headline News
Women less likely to use promotional language in research grant applications vs. men
December 11, 20243 min read